COMMUNIQUÉS West-GlobeNewswire

KFNCCC A Regional Leader in Pediatric Cancer Treatment

15/10/2024 - 15:18

RIYADH, Saudi Arabia, Oct. 15, 2024 (GLOBE NEWSWIRE) -- At the heart of advanced medical efforts in pediatric oncology in the Kingdom, King Fahad National Centre for Children's Cancer (KFNCCC), affiliated with King [...]

New AI Tool Helps Americans Get Immediate, Helpful Answers to HSA and Consumer-Directed Benefits Questions

15/10/2024 - 15:19

HSAnswers provides employees with quick access to benefits knowledge and helps benefits teams save time answering questions DRAPER, Utah, Oct. 15, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY) ("HealthEquity [...]

US Digestive Health Welcomes Seven New Physicians to Its Practice

15/10/2024 - 16:00

The physicians will support USDH’s expansion throughout Pennsylvania EXTON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- US Digestive Health (USDH), one of the nation’s largest gastroenterology (GI) practices, today announced [...]

WellRithms Launches Comp42: Expands Suite of Payment Integrity Services for Workers' Compensation Bill Review, Combats Overpayment and Expedites Dispute Resolution

15/10/2024 - 16:00

PORTLAND, Ore., Oct. 15, 2024 (GLOBE NEWSWIRE) -- WellRithms , the industry leading payment integrity firm, demonstrates its market leadership with the launch of Comp42 , designed to revolutionize workers' compensation [...]

Adia Nutrition Inc. Takes Major Steps Forward: Signs LOI for First Clinic and Engages Legal Expertise for Licensing

15/10/2024 - 16:00

WINTER PARK, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Adia Nutrition (OTC Pink: ADIA) is proud to announce a groundbreaking initiative in the fight against Multiple Sclerosis (MS) with the signing of a Letter of Intent ( [...]

ARC Fertility Selected for BenefitsPRO’s 2024 Luminaries Awards for Humanizing Benefits

15/10/2024 - 16:02

CUPERTINO, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- ARC Fertility (ARC), a highly experienced national provider of innovative fertility, family-forming and women’s and men’s health benefits for employers and their [...]

EUROAPI clôt le financement de son plan FOCUS-27

15/10/2024 - 17:45

Communiqué de presse Paris - Le 15 octobre 2024 - EUROAPI annonce avoir clos le refinancement du contrat de crédit RCF (Credit Revolving Facility) et l’Obligation Hybride Perpétuelle Super Subordonnée souscrite par [...]

EUROAPI closes the financing of its FOCUS-27 plan

15/10/2024 - 17:45

Press Release Paris - 15 October 2024 - EUROAPI today announces the closing of the refinanced Credit Revolving Facility (RCF) and the Perpetual Deeply Subordinated Hybrid Bond subscribed by Sanofi, thus completing the [...]

Trethera Announces Presentation at the Rare Neuroimmune Disorders Symposium Annual Meeting

15/10/2024 - 17:48

LOS ANGELES, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of [...]

SPINEWAY : Poursuite de la croissance organique - Chiffre d’affaires à 9 mois 2024 de 9,1 M€ (+ 21%)

15/10/2024 - 18:00

Communiqué de presse Ecully, le 15 octobre 2024 –18h SPINEWAY Poursuite de la croissance organique Chiffre d’affaires à 9 mois 2024 de 9,1 M€ (+ 21%) En milliers d’euros 2024 2023 Variation en % CA 1 er trimestre 3 070 [...]

Spineway : Continued organic growth - Nine-month 2024 revenue of €9.1 million (+21%)

15/10/2024 - 18:00

Press release Ecully, October 15, 2024 – 6 p.m. SPINEWAY Continued organic growth Nine-month 2024 revenue of €9.1 million (+21%) In thousands of euros 2024 2023 Change % Q1 revenue 3,070 2,398 28% Q2 revenue 3,465 3,033 [...]

Tevogen Bio Takes Lead in Developing Cell Therapies Designed to Eradicate Post Procedure Human Papilloma Virus in Women with Precancerous Cervical Lesions

15/10/2024 - 20:30

Approximately one in three women remain HPV positive after cervical procedures for precancerous lesions. Tens of thousands of women in the US each year are diagnosed with high-grade cervical precancerous lesions. These [...]

C4 Therapeutics Appoints Paige Mahaney, Ph.D., as Chief Scientific Officer and Announces Retirement of Stewart Fisher, Ph.D.

15/10/2024 - 22:01

Mahaney Brings More Than 25 Years of Pharmaceutical and Biotech Experience Overseeing Drug Discovery and Expansion of Leading Discovery and Clinical Portfolios Fisher Will Serve as Senior Scientific Advisor Until [...]

The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

15/10/2024 - 22:05

SCOTTSDALE, Ariz., Oct. 15, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) (“The Joint or “the Company”), the nation’s largest franchisor of chiropractic care through The Joint Chiropractic ® network, today [...]

Interpace Biosciences Announces Capital Restructuring of Its Preferred Stock as a First Step Toward Seeking an Uplisting of Its Common Stock to Nasdaq

15/10/2024 - 22:05

PARSIPPANY, NJ, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that its Series B Preferred Stock investors, Ampersand Capital Partners and 1315 [...]

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024

15/10/2024 - 22:05

SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its [...]

Sanofi: Informations relatives au nombre de droits de vote et d'actions - SEPTEMBRE 2024

15/10/2024 - 22:05

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]

Sanofi: Information concerning the total number of voting rights and shares - September 2024

15/10/2024 - 22:05

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]

Biodexa Announces Successful Appeal of Nasdaq Delisting

15/10/2024 - 22:15

Exhibit 99.1 October 15, 2024 Biodexa Announces Successful Appeal of Nasdaq Delisting Biodexa Pharmaceuticals PLC. (the “Company”) (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company [...]